James Lundy Assesses SEC Disgorgement Issues in Key Supreme Court Case
May 4, 2026
Bloomberg Law
Foley & Lardner LLP partner James Lundy assessed the U.S. Supreme Court’s consideration of SEC disgorgement powers in the Bloomberg Law article, “SEC Win on Core Enforcement Tool Would Still Leave Payback Gaps.”
Commenting on the agency’s practices regarding distribution to investors, he said, “Identifying victims, calculating amounts for a particular victim, potentially doing a distribution is something that the SEC does from time to time via its Fair Fund capabilities, but not something they do for all cases where they pursue disgorgement.”
(Subscription required)
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.